Emergent Biosolutions
EBS
EBS
211 hedge funds and large institutions have $854M invested in Emergent Biosolutions in 2022 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 80 increasing their positions, 70 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
211
Holders Change
-21
Holders Change %
-9.05%
% of All Funds
3.65%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
29
Increased
80
Reduced
70
Closed
47
Calls
$1.78M
Puts
$2.01M
Net Calls
-$234K
Net Calls Change
-$4.08M
Top Buyers
| 1 |
1
Man Group
London,
United Kingdom
|
$13.7M |
| 2 |
2
Balyasny Asset Management
Chicago,
Illinois
|
$11.5M |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$12.1M |
| 4 |
4
Federated Hermes
Pittsburgh,
Pennsylvania
|
$8.45M |
| 5 |
5
Pacer Advisors
Malvern,
Pennsylvania
|
$5.57M |
